Marksans Pharma Ltd Nine Monthly Results

Gross Sales

1,914.39

1,617.4

1,366.16

1,072.8

1,045.98

Excise Duty

0

0

0

0

0

Net Sales

1,914.39

1,617.4

1,366.16

1,072.8

1,045.98

Other Operating Income

0

0

0

0

0

Other Income

53.86

33.89

48.3

26.51

0.68

Total Income

1,968.24

1,651.29

1,414.47

1,099.3

1,046.67

Total Expenditure

1,511.5

1,268.46

1,136.39

877.56

801.75

PBIDT

456.74

382.83

278.08

221.75

244.92

Interest

8.23

6.36

6.69

3.42

5.16

PBDT

448.52

376.47

271.39

218.33

239.76

Depreciation

60.64

53.21

37.91

23.42

34.82

Minority Interest Before NP

0

0

0

0

0

Tax

104.31

82.99

51.36

39.75

49.2

Deferred Tax

-8.33

3.01

-0.49

-1.99

-3.3

Reported Profit After Tax

291.89

237.25

182.61

157.16

159.04

Minority Interest After NP

1.86

1.84

-1.77

0

0

Net Profit after Minority Interest

290.03

235.41

184.38

157.16

159.04

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

290.03

235.41

184.38

157.16

159.04

EPS (Unit Curr.)

6.4

5.19

4.54

3.82

3.83

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

45.32

45.32

40.3

40.93

40.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

23.85

23.66

20.35

20.67

23.41

PBDTM(%)

23.42

23.27

19.86

20.35

22.92

PATM(%)

15.24

14.66

13.36

14.64

15.2